H2O2 when accumulated is toxic to body tissues or cells
So, while GLP-1s might be helpful, the risk-benefit trade off for these groups might not be worth it
More recently, a small-molecule APJ agonist partnered with BioAge failed in clinical development due to hepatotoxicity unrelated to target engagement, highlighting that off-target toxicity can arise independently of the signaling bias hypothesis (Ryffel et al., 2023)
Where BPC-157 and TB-500 Fall Short On the other hand, I have not seen these peptides provide much benefit for chronic injuries
IGF-1 LR3 is an 83-amino-acid analog of native IGF-1 (70 amino acids) with a 13-amino-acid N-terminal extension and a glutamic-acid-to-arginine substitution at position 3
Cagrilintide is a long-acting DACRA and it is phase 3 study in a combination called CagriSema, a combination of semaglutide and cagrilintide [39]